MM
Therapeutic Areas
Cleara Biotech Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CL04177 | Metastatic Colorectal Cancer (mCRC), Triple-Negative Breast Cancer (TNBC), solid tumors, hematological malignancies | Pre-clinical |
| CL04183 | Metastatic Colorectal Cancer (mCRC), Triple-Negative Breast Cancer (TNBC), solid tumors, hematological malignancies | Pre-clinical |
| FOXO4/p53 Peptide Platform | Various cancers and chronic diseases driven by specific senescence subtypes | Discovery/Pre-clinical |